+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The role of anticoagulant therapy in hemorrhagic transformation of acute ischaemic stroke in nonvalvular atrial fibrillation patients



The role of anticoagulant therapy in hemorrhagic transformation of acute ischaemic stroke in nonvalvular atrial fibrillation patients



European Journal of Neurology 26(2): E24-E24




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066079923

Download citation: RISBibTeXText

PMID: 30632267

DOI: 10.1111/ene.13808


Related references

Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and Outcomes. Journal of the American Heart Association 7(22): E010133-E010133, 2018

The relationship between stroke severity and prior direct oral anticoagulant therapy in patients with acute ischaemic stroke and non-valvular atrial fibrillation. European Journal of Neurology 24(11): 1399-1406, 2017

Very low-intensity anticoagulant therapy in elderly cardioembolic stroke patients with nonvalvular atrial fibrillation. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 31(9): 711-715, 1994

Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study. International Journal of Stroke 10(6): 836-842, 2016

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation. Circulation. Cardiovascular Quality and Outcomes 8(2 Suppl 1): S12-S20, 2015

Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation. Journal of the American College of Cardiology 61(17): 1790-1798, 2013

Incidence of ischemic stroke and systemic embolism in patients with hypertrophic cardiomyopathy, nonvalvular atrial fibrillation, CHA2DS2-VASc score of ≤1 and without anticoagulant therapy. Heart and Vessels 31(7): 1148-1153, 2017

Detecting nonvalvular atrial fibrillation and anticoagulant therapy in cardioembolic ischemic stroke. Postgraduate Medicine 128(6): 620-628, 2017

Late recurrence of embolic stroke after discontinuation of anticoagulant therapy in nonvalvular atrial fibrillation. Journal of Neurology 235(8): 499-500, 1988

Anticoagulant Use in High Stroke-Risk Patients With Nonvalvular Atrial Fibrillation. Consultant Pharmacist 33(9): 521-530, 2018

Hemorrhagic Transformation After Acute Ischemic Stroke in Atrial Fibrillation Patients. Journal of Stroke and Cerebrovascular Diseases 28(1): 234-234, 2018

Hemorrhagic Transformation After Acute Ischemic Stroke in Atrial Fibrillation Patients. Journal of Stroke and Cerebrovascular Diseases 2018, 2018

Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. JAMA 279(16): 1273-1277, 1998

Left Atrial Size and Long-Term Risk of Recurrent Stroke After Acute Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation. Journal of the American Heart Association 6(8), 2018

Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention. Journal of Stroke and Cerebrovascular Diseases 26(10): 2102-2110, 2017